Research & Development

日日夜夜鲁鲁播放在线天天穞日日穞夜夜穞武磊成西班牙人冬窗最值引援 完爆另外两名队友


  霍去病瞅著雲瑯道︰“我們應該多去看看陛下,我們如果不去,陛下就會被奸佞之輩包圍,對大漢不利,對我們也不利。”   “為何?”日日夜夜鲁   這樣的聚會對主人來說是一件非常勞累的事情,雲氏上下玩的很開心,也非常的疲憊。鲁播放在线   “如果是人呢?”   “啪!”天天穞日日穞夜夜穞   “妾身就怕這孩子觸怒陛下!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo